Simona Tavecchio (S Tavecchio)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 11

Top Topics

Antiretroviral Therapy

Coronavirus Disease

Atopic Dermatitis

Top Venues

Journal of clinical medicine

Journal of the European Academy of Dermatology and Venereology : JEADV

Clinical and experimental dermatology

Rheumatology international

This page only lists publications with an associated author ORCID identifier.

Publications

Silvia Mariel Ferrucci, Simona Tavecchio, Alessandro Ceresa, Luisa Angileri, Emilio Berti, Angelo Valerio Marzano, Massimiliano Buoli
Which Factors Are Associated with Persistence of Depressive and Anxiety Symptoms in Patients Affected by Atopic Dermatitis despite 2-Year Treatment with Dupilumab? Journal of clinical medicine 13 (7) (2024)
Silvia Mariel Ferrucci, Simona Tavecchio, Alessandro Ceresa, Luisa Angileri, Emilio Berti, Angelo Valerio Marzano, Massimiliano Buoli
Which Factors Are Associated with Persistence of Depressive and Anxiety Symptoms in Patients Affected by Atopic Dermatitis despite 2-Year Treatment with Dupilumab? Journal of clinical medicine 13 (7) (2024)
Silvia Mariel Ferrucci, Simona Tavecchio, Alessandro Ceresa, Luisa Angileri, Emilio Berti, Angelo Valerio Marzano, Massimiliano Buoli
Which Factors Are Associated with Persistence of Depressive and Anxiety Symptoms in Patients Affected by Atopic Dermatitis despite 2-Year Treatment with Dupilumab? Journal of clinical medicine 13 (7) (2024)
Silvia Mariel Ferrucci, Giovanni Casazza, Martina Zussino, Simona Tavecchio, Angelo Valerio Marzano, Micol Tedeschi
Predictive Factors of Early Response to Dupilumab in Patients with Moderate-to-Severe Atopic Dermatitis. Journal of clinical medicine 12 (20) (2023)
E Nettis, S M Ferrucci, Giovanni Pellacani, Elisabetta Di Leo, Giuseppe Argenziano, C Foti, F Rongioletti, C Patruno, M Ortoncelli, L Macchia, Simona Tavecchio, Laura Bonzano, D Di Bona, Giulia Calabrese, G Fabbrocini, null null
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (12) (2021)
S Ferrucci, M Romagnuolo, Luisa Angileri, E Berti, Simona Tavecchio
Safety of dupilumab in severe atopic dermatitis and infection of Covid-19: two case reports. Journal of the European Academy of Dermatology and Venereology : JEADV 34 (7) (2020)
Simona Tavecchio, Luisa Angileri, Francesco Pozzo Giuffrida, Francesca Germiniasi, Angelo Valerio Marzano, Silvia Ferrucci
Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients. Journal of clinical medicine 9 (9) (2020)
M Romagnuolo, L Angileri, Simona Tavecchio, Angelo Valerio Marzano, S Ferrucci
Safety and efficacy of dupilumab in a patient with severe atopic dermatitis and HIV infection, with 15 months of follow-up. Clinical and experimental dermatology 45 (6) (2020)
S M Ferrucci, Simona Tavecchio, E M Favale, Luisa Angileri, D Riva, M Romagnuolo, A E Beretta, Angelo Valerio Marzano
Effects of lockdown on health of patients with severe atopic dermatitis treated with dupilumab. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (1) (2020)
E Nettis, G Fabbrocini, M Ortoncelli, G Pellacani, G Argenziano, Elisabetta Di Leo, C Patruno, Luca Stingeni, C Foti, Franco Rongioletti, L Macchia, Simona Tavecchio, Maddalena Napolitano, Simone Ribero, Laura Bonzano, Giulia Calabrese, D Di Bona, S P Nisticò, K Hansel, Paolo Romita, V Piras, M Carbonara, Aikaterini Detoraki, S M Ferrucci
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients. The British journal of dermatology 184 (3) (2020)
Giovanni Genovese, Simona Tavecchio, Emilio Berti, Franco Rongioletti, Angelo Valerio Marzano
Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis: two cases and literature review. Rheumatology international 38 (6) (2018)